Last reviewed · How we verify

NCT03328390

Analgesia for Laparotomy in Cancer Patients: Quadratus Lumborum Block

Completed NA Last updated 6 November 2017
What this trial tests

NA trial testing Quadratus lumborum block in Cancer in 102 participants. Completed in 15 July 2017.

Timeline
12 January 2016
Primary endpoint
15 July 2017
15 July 2017

Quick facts

Lead sponsorAlaa Mazy
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment102
Start date12 January 2016
Primary completion15 July 2017
Estimated completion15 July 2017
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alaa Mazy — full company profile →

Who can join

Adults 20 to 60, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Regional anesthesia of the abdomen significantly reduce postoperative pain, spare the systemic opioids and decrease postoperative nausea and vomiting. Multiple regional techniques can be performed at the neuro-axis (epidural), the nerve root (paravertebral) and the peripheral nerve (transversus abdominis plane). Quadratus lumborum (QL) block is an addition into the league of truncal nerve block techniques that has been found to provide analgesia for abdominal surgeries. Several case reports have shown that local anesthetic injection around the quadratus lumborum muscle is effective in providing pain relief after various abdominal operations and in patients with chronic pain. The study hypothesis is that quadratus lumborum block in single shot may be more superior to transversus abdominus plane block as regard intra-operative and the post-operative analgesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Quadratus lumborum block

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Alaa Mazy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03328390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing